FDA Unveils Top 5 QMSR Inspection Findings as MedTech Firms Adjust to New Rule
May 12, 2026
Early FDA inspection data under the new QMSR framework points to persistent weaknesses in how companies manage risk, oversee suppliers, investigate complaints, maintain UDI compliance,